Login

Research: It's All About Patients - Dr. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Research: It's All About Patients

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Burkhalter CEO Zeno Böhm Reflects on 2023 Performance and Unveils Acquisition Strategy | Zeno Bohm - CEO of burkhalter holding ag
00:10:00
First Gen Corp. reported a net income of P15.4 billion in 2023, reflecting strong financial performance.
00:10:00
Mastering Volatility and Skew to Deliver Rare Alpha in Crowded, Convex Markets|Nigol Koulajian,CIO,AlphaQuest
00:10:00
2023 RIU Resurgence: Q&A with Damian Connelly | DAMIAN CONNELLY, Principal Consulting Engineer of METS Engineering
00:10:00
Navigating the New Phase of Oil and Gas Investments | Kate Richard, Founder and CEO, Warwick Energy Group.
00:10:00
Vow and C.H. Evensen Partner to Decarbonize Industries: A Pathway to Carbon Neutral Energy | Henrik Badin, CEO, Vow ASA.
00:10:00
Exploring Alternative Retirement Planning Strategies
00:10:00
Convincing entrepreneurs from the early stages of company, protocol, and network building|Amanda Niu,CFO & General Partner,Shine Capital
00:10:00
Educational Quality and Economic Growth: Insights from OECD Study|Ludger Wößmann
00:10:00
Government Resources Advances Burkina Faso Gold Project with Upcoming Resource Estimate
00:10:00
veon CEO Kaan Terzioğlu believes that emerging markets can be more progressive and forward-looking.
00:10:00
Exploring Innovative ETF Opportunities with John Porter | John Porter, CIO , Newton Investment Management .

© 2017 - Neuhu+